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Insulin resistance is a key pathophysiological feature of metabolic syndrome. However, the initial 
events triggering the development of insulin resistance and its causal relations with dysregulation of 
glucose and fatty acids metabolism remain unclear. We investigated biological pathways that have the 
potential to induce insulin resistance in mice fed a high-fat diet (HFD). We demonstrate that the 
pathways for reactive oxygen species (ROS) production and oxidative stress are coordinately 
up-regulated in both the liver and adipose tissue of mice fed a HFD prior to the onset of insulin 
resistance through discrete mechanism. In the liver, a HFD up-regulated genes involved in sterol 
regulatory element binding protein-1c (SREBP-1c)-related fatty acid synthesis and peroxisome 
proliferator-activated receptor-α (PPARα)-related fatty acid oxidation. In the adipose tissue, however, 
the HFD down-regulated genes involved in fatty acid synthesis and up-regulated NADPH oxidase 
(Nox) complex. Furthermore, increased ROS production preceded the elevation of TNF-α and free 
fatty acids (FFAs) in the plasma and liver. ROS may be an initial key event triggering HFD-induced 
insulin resistance. 
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Insulin resistance and obesity are generally brought about by an excessive nutrient 
condition, attributable to an imbalance among energy intake, expenditure, and storage. Importantly, 
liver and adipose tissue jointly participate in maintaining glucose and lipid homeostasis through the 
secretion of various humoral factors and/or neural networks [1-3]. Previous studies have validated the 
presence of molecular signatures typical of the liver and adipose tissue in mouse models of obesity [4] 
and in mice fed a high-fat diet (HFD) [5]. It is believed that perturbations in these ‘intertissue 
communications’ may be involved in the development of insulin resistance, obesity, and other 
features of metabolic syndrome [6]. It remains unclear however, which factors alter communication 
among tissues and impair the ability of tissues to adapt to changing metabolic states. 
To determine which initial events trigger the development of HFD-induced insulin 
resistance and obesity, we globally analyzed the biological pathways that are coordinately altered in 
both the liver and adipose tissue of mice fed a HFD. This was accomplished through the use of 
microarray and quantitative real-time PCR analyses. We found that oxidative stress pathways, which 
are regulated through the balance of ROS production and antioxidant enzyme activity [7], are 
up-regulated in both tissues prior to the onset of insulin resistance and obesity induced by a HFD. 
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2. Materials and methods 
 
2.1. Animals and experimental design.  
    
 Male C57BL/6J mice were purchased from Charles River Laboratories Japan (Yokohama, Japan) at 
6 weeks of age. After a 2-week acclimation period, the mice were divided randomly into two groups: 
(a) mice given a standard chow containing 5.9% fat (in the form of soybean oil) by weight (control, n 
= 10), and (b) mice given a high-fat diet containing 60% fat (in the form of cocoa butter) by weight 
(HFD, n = 10). Both diets used in this study were prepared by Oriental Yeast (Tokyo, Japan). The 
mice were housed in a room maintained at a controlled temperature (23 ± 1°C) and a 12-h light/12-h 
dark cycle. In addition, animals were given free access to water and food. All animal procedures were 
in accordance with the Guidelines for the Care and Use of Laboratory Animals at the Takara-machi 
campus of Kanazawa University, Japan. 
 
2.2. Glucose and insulin tolerance tests.  
 
    For the oral glucose tolerance test (GTT), mice were fasted for 12 h before glucose was 
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administered at 1.5 g/kg body weight. For the insulin tolerance test (ITT), mice were injected 
intraperitoneally with insulin (0.5 U/kg body weight, Humulin R; Eli Lilly Japan, Kobe, Japan) 
following a 4-h fast. Glucose values were measured in whole venous blood using a blood glucose 
monitoring system (FreeStyle; Kissei, Matsumoto, Japan) at 0, 15, 30, 60, and 120 min after the 
administration of either glucose or insulin. 
 
2.3. Tissue preparation, blood sampling, and analysis. 
 
     Following a 12-h fast, blood samples were obtained from the tail vein. Mice were then sacrificed 
by cervical dislocation under diethyl ether anesthesia. The liver and adipose tissue (retroperitoneal 
fat) were immediately removed and weighed. A large portion of tissue was snap-frozen in liquid 
nitrogen for later RNA analysis. Enzymatic assays for total cholesterol, FFAs, and triglycerides were 
performed using commercial kits purchased from Wako (Osaka, Japan). The plasma level of TNF-α 
was measured with a mouse TNF-α ELISA kit (Pierce Biotechnology, Rockford, IL). 
 
2.4. Measurement of hepatic lipid content. 
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     Hepatic lipids were extracted with chloroform:methanol (2:1) according to previously published 
methods [8]. The resulting extract was dissolved in water and subsequently analyzed for triglycerides, 
total cholesterol, and FFAs using commercial kits (Wako). 
 
2.5. Measurement of oxidative stress in liver and adipose tissue.  
 
    The concentration of proteins containing carbonyl groups in the liver and retroperitoneal fat (those 
which react with 2,4-dinitrophenylhydrazine to form the corresponding hydrazone) was determined 
spectrophotometrically according to commercial kit instructions (protein carbonyl assay kit; Cayman 
Chemical, Ann Arbor, MI).  
 
2.6. RNA preparation for microarray and hybridization analysis.  
 
    Total RNA was isolated from the frozen liver and retroperitoneal fat using a ToTALLY RNA kit 
(Applied Biosystems, Foster City, CA) and a RNeasy Lipid Tissue Mini kit (Qiagen, Germantown, 
MD), respectively. Each sample was prepared by pooling equal amounts of total RNA from three 
mice of the same experimental or control group. Three micrograms of total RNA were used for the 
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synthesis of amino allyl antisense RNA with an Amino Allyl MessageAmp II aRNA kit (Applied 
Biosystems). These samples were then used for oligo-microarrays (AceGene Mouse 30K, DNA Chip 
Research, Yokohama, Japan). The microarray hybridization sample and reference antisense RNA 
were labeled with Cy5 and Cy3, respectively. Hybridization and washing were performed according 
to the manufacturer’s instructions. The microarray was scanned using a G2505B microarray scanner 
(Agilent Technologies, Palo Alto, CA), and the image was analyzed using GenePix Pro 4.1 software 
(Axon Instruments, Union City, CA). An arbitrary cut-off signal value (<50) for both colors was used 
to filter genes with low expression values. Data were normalized (LOWESS method) using 
GeneSpring v7.2 software (Agilent Technologies). For pathway analysis, we used the GenMAPP and 
MAPPFinder software packages [9]. The GenMAPP program contains many pathway maps that can 
be associated with imported microarray data. The MAPPFinder program, which links gene 
expression data to the pathway maps, can calculate the z score (standardized difference score) and the 
percentage of genes measured that meet user-defined criteria (±20% in change-fold in our analysis). 
Using the z score and the percentage, the pathways were ranked by the relative amount of gene 
expression changes. 
 
2.7. Quantitative real-time PCR.  
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   Total RNA (100 ng of the same sample used for microarray analysis) was reverse transcribed using 
random primers and SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA). PCR was 
performed on an ABI PRISM 7900HT (Applied Biosystems). The specific PCR primers and TaqMan 
probes were obtained from Applied Biosystems. The PCR conditions were one cycle at 50°C for 2 
min and 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. 
 
2.8. Statistical analysis.  
 
    All results are reported as means ± SD. Between-group differences in continuous variables were 
assessed by univariate analysis using Student’s t-test. All calculations were performed with SPSS 




3.1. Effects of the HFD on metabolic parameters 
 
 As shown in Table 1, no differences were observed in any parameters between the HFD 
and control mice after 6 weeks of treatment. After 24 weeks, mice fed the HFD weighed significantly 
more and had more visceral fat compared with control mice. Fasting plasma insulin levels were 
significantly higher in mice fed the HFD than in control mice. The HFD also induced the 
accumulation of FFAs in the liver after 24 weeks. These results suggest that mice fed the HFD 
maintained metabolic homeostasis up to 6 weeks, at which point obesity and insulin resistance 
developed. 
 
3.2. Effects of the HFD on insulin sensitivity 
 
 To evaluate insulin sensitivity, GTT and ITT were conducted after 6 and 24 weeks of 
treatment in both groups (Fig. 1). Although there was no significant difference in the blood glucose 
level between the HFD and control mice at 6 weeks, the HFD mice exhibited impaired glucose 
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tolerance (Fig. 1A) and insulin resistance (Fig. 1B) at 24 weeks. These results are consistent with the 
above observation that obesity, abdominal adiposity, and hyperinsulinemia were induced only after 
mice were fed the HFD for 24 weeks. 
 
3.3. Fatty acid metabolism pathways are differentially regulated in liver and adipose tissue of mice 
fed the HFD 
 We compared liver and adipose tissue gene expression data between mice fed the HFD and 
control mice after 6 weeks of treatment to identify pathways with the potential to induce insulin 
resistance (Table 2). The gene expression levels of various metabolic pathways were already altered 
at 6 weeks. In particular, pathways for SREBP-1c-related fatty acid synthesis (Fig. 2 and 
Supplementary Fig. 1A) and PPARα-related fatty acid oxidation were up-regulated in the liver of the 
HFD mice. In contrast, the pathway for fatty acid synthesis was down-regulated in the adipose tissue 
(Supplementary Fig. 1B). Such compensatory alterations in the expression of genes that regulate fatty 
acid metabolism seem to help maintain plasma and hepatic levels of FFAs, which have been 
considered to be a causal factor for insulin resistance [10, 11]. In the current study, these levels were 
similar between the HFD mice and control mice at 6 weeks (Table 1). 
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3.4. Oxidative stress pathways are coordinately up-regulated in both liver and adipose tissue of mice 
fed the HFD 
 In contrast to the pathways for fatty acid metabolism, oxidative stress pathways were 
coordinately up-regulated in both the liver and adipose tissue (Table 2, Supplementary Fig. 1C, D). 
The oxidative stress pathway is composed of genes for ROS production, stress signaling, and 
antioxidant enzymes. ROS are radical forms of oxygen that can arise from several biochemical 
reactions: (1) loading of excessive electrons in the respiratory chain by increased mitochondrial fatty 
acid β-oxidation [12], (2) peroxisomal fatty acid β-oxidation by acyl-CoA oxidase (Acox) [13], (3) 
microsomal fatty acid ω-oxidaiton by cytochrome P450 2E1 (CYP2E1) [14], and (4) reduction of 
oxygen by the Nox complex [15].  
To determine the sources of ROS in the liver and adipose tissue of mice fed the HFD, we 
examined the mRNA expression levels of genes involved in ROS production through the use of 
quantitative real-time PCR (Fig. 2). In the liver of mice fed a HFD for 6 weeks, the expression levels 
of genes encoding key regulators of mitochondrial fatty acid β-oxidation, including PPARα, carnitine 
palmitoyltransferase 1a (CPT-1a), Acox1, and CYP2E1, were significantly up-regulated (1.6-, 2.0-, 
1.5-, and 1.5-fold, respectively) compared with control mice, whereas the expression levels of Nox2, 
Nox4, and the Nox complex components p22phox and p47phox were similar between HFD mice and 
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control mice. In the adipose tissue of mice fed a HFD for 6 weeks, gene expression levels of Acox1, 
CYP2E1, Nox4, and p22phox were significantly up-regulated (1.6-, 1.4-, 2.3-, and 1.6-fold, 
respectively) compared with control mice; in contrast to the liver, the adipose tissue did not show 
up-regulated expression of the genes for PPARα and CPT-1a. These results suggest that the source of 
ROS may differ according to the specific tissue, such that a HFD may induce ROS production in 
distinctly different manners in the liver and adipose tissue. A HFD may induce ROS production 
through fatty acid oxidation in the mitochondria of the liver but via Nox in the adipose tissue. 
Oxidative stress is regulated by the balance between ROS production and antioxidant 
enzyme activity (7). Consequently, we determined the expression levels of the genes for glutathione 
peroxidase (Gpx) and Mn-superoxide dismutase (Mn-SOD), both of which reduce ROS and lipid 
peroxides, resulting in decreased oxidative stress (Fig. 2). The expression level of the Gpx1 gene was 
significantly up-regulated (3.4-fold) in the adipose tissue, but not in the liver, of mice fed the HFD 
compared with control mice. The insufficient up-regulation of antioxidant enzymes may therefore 
cause more oxidative stress in the liver than in the adipose tissue.  
The proinflammatory cytokine TNF-α, which is elevated in obese rodents and humans, is 
also an important contributor to the development of insulin resistance [16]. However, the mRNA 
expression level of TNF-α in the liver and adipose tissue of mice fed the HFD for 6 weeks was similar 
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to that of control mice (Fig. 2). Furthermore, the plasma level of TNF-α was below the detection limit 
of the ELISA (<10 pg/mL) in both groups. These results suggest that the up-regulation of genes for 
ROS production, rather than the elevation of TNF-α, may be an early event triggering insulin 
resistance in mice fed a HFD.  
 
3.5. Evaluation of oxidative stress in the liver and adipose tissue of mice fed the HFD 
 
 To confirm whether high fat intake increases oxidative stress, we measured the protein 
carbonyl level (marker for cumulative oxidative stress) in the liver and adipose tissue. As expected, 
the protein carbonyl level was elevated by 35% in the liver but was not altered in the adipose tissue of 
mice fed the HFD compared with control mice at 6 weeks (Fig. 3). The up-regulation of antioxidant 




ROS production is one of many factors that have been suggested to play a role in the 
development of insulin resistance, based on the following evidence: (1) high doses of hydrogen 
peroxide [17] and reagents that accumulate ROS [18] can induce insulin resistance in 3T3-L1 
adipocytes, and (2) increased markers of oxidative stress were observed in obese humans [19] and 
rodents [17, 20]. It remains unclear, however, whether increased ROS production causes insulin 
resistance in vivo. In this study, we demonstrated that the up-regulation of genes responsible for ROS 
production occurs in both the liver and adipose tissue prior to the onset of insulin resistance and 
obesity in mice fed a HFD. 
In our dietary model of insulin resistance, the mRNA up-regulation of genes for fatty acid 
oxidation was observed in the liver. Previous studies have also shown that fatty acid oxidation was 
increased in the liver to compensate for high fat intake [21]. In addition, pathways involved in the 
mitochondrial respiratory chain were coordinately down-regulated in both the liver and adipose tissue 
of mice fed the HFD. These results are consistent with previous reports in skeletal muscle of both 
humans and mice [22]. High mitochondrial β-oxidation rates seem to help metabolize excess FFAs, 
although large amounts of electrons entering the respiratory chain may cause abnormal reduction of 
oxygen. An influx of electrons may then lead to increased mitochondrial ROS production. This 
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suggests that impaired respiratory chain function may cause increased mitochondrial ROS production. 
Furthermore, we speculate that the down-regulation of the respiratory chain may lead to an influx of 
FFAs to intracellular peroxisomes and microsomes instead of to mitochondria, resulting in further 
generation of ROS by Acox and CYP2E1, genes up-regulated in both liver and adipose tissue in this 
study. 
The Nox complex may be a major source of ROS production in adipose tissue but not in 
liver. Furukawa et al.[17] reported that the mRNA expression of Nox2 and its subunits p22phox, p47phox, 
and p67phox was significantly up-regulated in the adipose tissue of obese KKAy mice compared with 
lean C57BL/6J mice. In the present study, however, the HFD up-regulated only Nox4 and p22phox 
expression in adipose tissue. This discrepancy may be attributed to the difference between genetically 
and HFD-induced obese models. Given that complexes of Nox4 with p22phox increase in the kidney of 
diabetic rats [23], excessive nutrients (e.g., high fat intake) may also induce ROS production via the 
Nox4/p22phox complex. 
It is striking that increased ROS production preceded the elevated levels of TNF-α and 
FFAs in the plasma and liver. Although TNF-α and FFAs are thought to cause insulin resistance, our 
results raise the possibility that ROS trigger the development of insulin resistance, resulting in 
abdominal obesity and elevated TNF-α and FFAs. In summary, the HFD induced oxidative stress, 
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potentially through the up-regulated expression of genes for ROS production, in the liver and adipose 
tissue. In addition, these changes occurred prior to the onset of insulin resistance and obesity. Sources 
of ROS induced by a HFD may differ between the liver and adipose tissue. These findings suggest 
that ROS production may be the initial event triggering HFD-induced insulin resistance and therefore 
may be an attractive therapeutic target for preventing insulin resistance and obesity caused by a HFD. 
 
Acknowledgements 
We thank A. Katayama and M. Nakamura for technical assistance. 
 18 
References 
[1] Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, et al. Adiponectin 
stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein 
kinase. Nat Med 2002;8:1288-1295. 
[2]  Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, Messaddeq N, et al. 
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. 
Nature 2006;439:484-489. 
[3]  Uno K, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Imai J, Hasegawa Y, et al. Neuronal 
pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 
2006;312:1656-1659. 
[4]  Lan H, Rabaglia ME, Stoehr JP, Nadler ST, Schueler KL, Zou F, Yandell BS, et al. Gene 
expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic 
capacity in diabetes susceptibility. Diabetes 2003;52:688-700. 
[5]  Gregoire FM, Zhang Q, Smith SJ, Tong C, Ross D, Lopez H, West DB. Diet-induced obesity and 
hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol 
Endocrinol Metab 2002;282:E703-713. 
[6]  Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis 
 19 
and metabolic harmony. J Clin Invest 2006;116:1767-1775. 
[7]  Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin 
system. Free Radic Biol Med 2001;31:1287-1312. 
[8]  Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total 
lipides from animal tissues. J Biol Chem 1957;226:497-509. 
[9]  Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: 
using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray 
data. Genome Biol 2003;4:R7. 
[10] Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 
1997;46:3-10. 
[11] Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, et al. Free fatty acids 
produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat 
liver. Diabetes 2005;54:3458-3465. 
[12] St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from 
different sites in the mitochondrial electron transport chain. J Biol Chem 2002;277:44784-44790. 
[13] Osmundsen H, Bremer J, Pedersen JI. Metabolic aspects of peroxisomal beta-oxidation.  
Biochim Biophys Acta 1991;1085:141-158. 
 20 
[14] Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 
2001;21:27-41. 
[15] Krieger-Brauer HI, Kather H. Human fat cells possess a plasma membrane-bound 
H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor 
kinase. J Clin Invest 1992;89:1006-1013. 
[16] Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis 
factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91. 
[17] Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, et al. 
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 
2004;114:1752-1761. 
[18] Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, et al. The 
hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. 
J Biol Chem 2005;280:4617-4626. 
[19] Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, et al. 
Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol 
Metab 2003;88:4673-4676. 
[20] Diniz YS, Rocha KK, Souza GA, Galhardi CM, Ebaid GM, Rodrigues HG, Novelli Filho JL, et 
 21 
al. Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and 
oxidative stress in rats. Eur J Pharmacol 2006;543:151-157. 
[21] Akbiyik F, Cinar K, Demirpence E, Ozsullu T, Tunca R, Haziroglu R, Yurdaydin C, et al. 
Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of 
fatty acid oxidation enzymes in fatty liver. Eur J Clin Invest 2004;34:429-435. 
[22] Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR. A high-fat diet 
coordinately downregulates genes required for mitochondrial oxidative phosphorylation in 
skeletal muscle. Diabetes 2005;54:1926-1933. 
[23]Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, et al. 
Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of 






Fig. 1. Evaluation of glucose tolerance and insulin sensitivity.  
GTT (A) and ITT (B) after 6 or 24 weeks of standard chow or the HFD. Values represent the means ± 
SD for five mice. *P < 0.05 versus the control group.  
 
Fig. 2. Quantitative real-time PCR for representative genes involved in fatty acid metabolism and 
oxidative stress.  
The mRNA levels of SREBP-1c, Fatty acid synthase, PPARα, CPT-1a, Acox1, CYP2E1, Nox2, Nox4, 
p22phox, p47phox, Gpx1, Mn-SOD, and TNF-α in the liver or retroperitoneal fat of mice fed standard 
chow (n = 3) or the HFD (n = 3) were quantified using real-time PCR after 6 weeks of feeding. The 
RNA samples for real-time PCR were the same as those for the microarray analysis. Gene expression 
levels were normalized to 18S rRNA. The degree of change in gene expression is based on the mean 
expression level of control mice. Values represent the means ± SD for three mice. *P < 0.05 and **P 
< 0.01 versus the control mice.  
 
Fig. 3. Measurement of protein carbonyl levels in the liver and adipose tissue.  
Protein carbonyl concentration was analyzed as a marker for oxidative stress in the liver and 
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Table 1. Clinical and biochemical parameters of mice fed the standard chow or high-fat 
diet (HFD) after 6 or 24 weeks.   
         
 24 
  6 weeks 24 weeks 
Diet type control HFD control HFD 
Body weight (g) 25.1±0.9 26.5±1.4 29.0±1.5 35.2±3.8* 
Liver weight (g) 1.11±0.09 1.03±0.12 1.28±0.07 1.20±0.23 
Retroperitoneal fat pad weight (g) 0.07±0.05 0.10±0.08 0.24±0.09 0.61±0.17**
Plasma triglycerides (mg/dL) 69.1±9.0 75.0±18.9 41.5±9.2 63.0±15.0 
Plasma total cholesterol (mg/dL) 85.0±7.4 117.7±37.0 84.6±7.9 132.6±26.1*
Plasma FFAs (mEq/L) 0.60±0.16 0.61±0.21 0.48±0.09 0.54±0.16 
Plasma TNF-α (pg/mL) <10 <10 N.D. N.D. 
Fasting plasma insulin (μU/mL) 14.6±3.6 18.1±7.6 15.7±6.2 43.3±14.3*
Hepatic triglycerides (μg/mg protein) 64.8±23.2 73.8±15.4 148.6±46.7 143±43.0 
Hepatic total cholesterol (μg/mg protein) 43.0±6.3 40.8±6.0 34.3±4.9 36.5±4.5 
Hepatic FFAs (μEq/mg protein) 46.7±6.9 48.8±3.6 53.1±4.0 71.0±7.6* 
Values represent the means ± SD of 5 mice per group. FFAs, free fatty acids. N.D., not determined. 




Table 2. Biological pathways of liver or adipose tissue genes regulated by the HFD after 6 weeks 







P value z score Pathway name 
    
Liver     
   Up-regulated    
Cholesterol biosynthesis 10 15 4.61 < 0.001 
Fatty acid synthesis   9 14 4.23 < 0.001 
Oxidative stress   16 38 3.52 0.001  
Glucocorticoid mineralocorticoid metabolism 7 12 3.39 0.006  
Statin pathway 9 19 3.06 0.005  
Glycolysis and gluconeogenesis 14 41 2.37 0.018  
Fatty acid beta oxidation 10 27 2.30 0.021  
Down-regulated       
Electron transport chain (= respiratory chain) 28 82 4.77  < 0.001 
ACE-inhibitor pathway 5 8 3.72  0.003  
     
Adipose tissue     
   Up-regulated    
TGF Beta signaling pathway 27 50 3.645 0.001 
Complement and coagulation cascades 29 59 3.149 0.001 
Adipogenesis 51 129 2.638 0.014 
Oxidative stress 18 38 2.287 0.026 
Smooth muscle contraction 61 157 2.282 0.024 
Inflammatory response pathway 18 40 2.018 0.037 
Down-regulated      
Focal adhesion 74 189 3.50 < 0.001 
Glycolysis and gluconeogenesis 21 41 3.35 < 0.001 
Electron transport chain (= respiratory chain) 35 82 3.01 0.002 
Krebs-TCA cycle 14 29 2.46 0.020 
Fatty acid synthesis   8 14 2.45 0.029 
Pentose phosphate pathway 5 8 2.19 0.038 
Pathway analysis was performed using MAPPFinder 2.0 and the Mm-std 20051114.gdb data base. 
The criteria for genes with significantly increased or decreased expression were change-fold (ratio 
to control) >20% (i.e. >1.20 or <0.83). For each pathway, the number of genes that meet the criteria 
for a significant increase or decrease was determined. This number was compared with the number 
pathway genes detected by microarray analysis. These value were used to calculate of z score and 
the permuted P value. Pathways indicated by arrows were coordinately regulated between in the 
liver and adipose tissue (retroperitoneal fat). On the other hand, pathways for fatty acid synthesis 
and glycolysis and gluconeogenesis were up-regulated in the liver (highlighted in red) and 
down-regulated in adipose tissue (highlighted in green).  
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Legends for supplementary figure 
Supplementary Fig. 1. Illustration of the pathways for fatty acid synthesis and oxidative 
stress in the liver and adipose tissue. The genes involved in fatty acid synthesis were 
up-regulated in the liver of mice fed a HFD (A), whereas they were down-regulated in the 
adipose tissue (B). However, the genes involved in oxidative stress were coordinately 
up-regulated in both the liver (C) and retroperitoneal fat (D) of mice fed the HFD. Each 
pathway is adapted from a view in GenMAPP. The fold change presented beside the name of 
each gene is for mice fed the HFD compared with control mice. Genes up-regulated more 
than 1.2-fold or 2.0-fold by HFD are colored pink or red, respectively. Genes down-regulated 
more than 1.2-fold or 2.0-fold by HFD are colored pale green or green, respectively. Genes 
analyzed but not altered in mice fed the HFD are colored gray. 
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